The Food and Drug Administration approves lubiprostone for irritable bowel syndrome with constipation.
Lang
Les
L
D000527:Alprostadil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003248:Constipation / Q000188:drug therapy* / Q000209:etiology; D017277:Drug Approval; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000150:complications / Q000188:drug therapy*; D000068238:Lubiprostone; D014481:United States; D014486:United States Food and Drug Administration
D000068238:Lubiprostone; D000527:Alprostadil